Our study demonstrates that the expression of one specific HERV family, namely HERV-K(HML-2), correlates with liver cirrhosis as well as clinical parameters indicating impaired liver function, such as low albumin levels, in a cohort of HCV-infected patients treated with direct-acting antiviral (DAA) treatment. The gene discussed is CLEC10A; the disease is cirrhosis of liver.